+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Antidepressants - Market Analysis, Trends, and Forecasts

  • ID: 4845769
  • Report
  • October 2019
  • Region: Global
  • 261 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • H. Lundbeck A/S
  • Merck & Co., Inc.
  • Pfizer
  • MORE
The Antidepressants market worldwide is projected to grow by US$2.4 Billion, driven by a compounded growth of 2.3%. Major Depressive Disorder, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.5 Billion by the year 2025, Major Depressive Disorder will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$94.9 Million to the region's size and clout in the next 5 to 6 years. Over US$69.6 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Major Depressive Disorder will reach a market size of US$400.5 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$659.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Allergan PLC
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Merck & Co., Inc.
  • Otsuka America Pharmaceutical, Inc.
  • Pfizer, Inc.
  • Takeda Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • H. Lundbeck A/S
  • Merck & Co., Inc.
  • Pfizer
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Antidepressants Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Antidepressants Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Antidepressants Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Antidepressants Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Major Depressive Disorder (Disorder) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Major Depressive Disorder (Disorder) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Major Depressive Disorder (Disorder) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Obsessive-Compulsive Disorder (Disorder) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Obsessive-Compulsive Disorder (Disorder) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Obsessive-Compulsive Disorder (Disorder) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Generalized Anxiety Disorder (Disorder) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Generalized Anxiety Disorder (Disorder) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Generalized Anxiety Disorder (Disorder) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Panic Disorder (Disorder) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Panic Disorder (Disorder) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Panic Disorder (Disorder) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Other Disorders (Disorder) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Other Disorders (Disorder) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Other Disorders (Disorder) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Tricyclic Antidepressants (Product) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Tricyclic Antidepressants (Product) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Tricyclic Antidepressants (Product) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Selective Serotonin Reuptake Inhibitors (Product) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Selective Serotonin Reuptake Inhibitors (Product) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Selective Serotonin Reuptake Inhibitors (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Serotonin-Norepinephrine Reuptake Inhibitors (Product) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 26: Serotonin-Norepinephrine Reuptake Inhibitors (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 27: Serotonin-Norepinephrine Reuptake Inhibitors (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Monoamine Oxidase Inhibitors (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 29: Monoamine Oxidase Inhibitors (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 30: Monoamine Oxidase Inhibitors (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 31: Serotonin Antagonist & Reuptake Inhibitors (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 32: Serotonin Antagonist & Reuptake Inhibitors (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 33: Serotonin Antagonist & Reuptake Inhibitors (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: Other Products (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 35: Other Products (Product) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 36: Other Products (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Antidepressants Market Share (in %) by Company: 2019 & 2025

TABLE 37: United States Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025

TABLE 38: Antidepressants Market in the United States by Disorder: A Historic Review in US$ Million for 2009-2017

TABLE 39: United States Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 40: United States Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 41: Antidepressants Market in the United States by Product: A Historic Review in US$ Million for 2009-2017

TABLE 42: United States Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

CANADA

TABLE 43: Canadian Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025

TABLE 44: Canadian Antidepressants Historic Market Review by Disorder in US$ Million: 2009-2017

TABLE 45: Antidepressants Market in Canada: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025

TABLE 46: Canadian Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 47: Canadian Antidepressants Historic Market Review by Product in US$ Million: 2009-2017

TABLE 48: Antidepressants Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

JAPAN

TABLE 49: Japanese Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025

TABLE 50: Antidepressants Market in Japan: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017

TABLE 51: Japanese Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025

TABLE 52: Japanese Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 53: Antidepressants Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 54: Japanese Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025

CHINA

TABLE 55: Chinese Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025

TABLE 56: Antidepressants Historic Market Analysis in China in US$ Million by Disorder: 2009-2017

TABLE 57: Chinese Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 58: Chinese Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 59: Antidepressants Historic Market Analysis in China in US$ Million by Product: 2009-2017

TABLE 60: Chinese Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Antidepressants Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 61: European Antidepressants Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 62: Antidepressants Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 63: European Antidepressants Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 64: European Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025

TABLE 65: Antidepressants Market in Europe in US$ Million by Disorder: A Historic Review for the Period 2009-2017

TABLE 66: European Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 67: European Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 68: Antidepressants Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 69: European Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

FRANCE

TABLE 70: Antidepressants Market in France by Disorder: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 71: French Antidepressants Historic Market Scenario in US$ Million by Disorder: 2009-2017

TABLE 72: French Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025

TABLE 73: Antidepressants Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 74: French Antidepressants Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 75: French Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025

GERMANY

TABLE 76: Antidepressants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025

TABLE 77: German Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017

TABLE 78: German Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 79: Antidepressants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 80: German Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 81: German Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

ITALY

TABLE 82: Italian Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025

TABLE 83: Antidepressants Historic Market Analysis in Italy in US$ Million by Disorder: 2009-2017

TABLE 84: Italian Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 85: Italian Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 86: Antidepressants Historic Market Analysis in Italy in US$ Million by Product: 2009-2017

TABLE 87: Italian Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 88: United Kingdom Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025

TABLE 89: Antidepressants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017

TABLE 90: United Kingdom Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025

TABLE 91: United Kingdom Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 92: Antidepressants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 93: United Kingdom Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025

SPAIN

TABLE 94: Spanish Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025

TABLE 95: Spanish Antidepressants Historic Market Review by Disorder in US$ Million: 2009-2017

TABLE 96: Antidepressants Market in Spain: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025

TABLE 97: Spanish Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 98: Spanish Antidepressants Historic Market Review by Product in US$ Million: 2009-2017

TABLE 99: Antidepressants Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

RUSSIA

TABLE 100: Russian Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025

TABLE 101: Antidepressants Market in Russia by Disorder: A Historic Review in US$ Million for 2009-2017

TABLE 102: Russian Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 103: Russian Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 104: Antidepressants Market in Russia by Product: A Historic Review in US$ Million for 2009-2017

TABLE 105: Russian Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 106: Rest of Europe Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025

TABLE 107: Antidepressants Market in Rest of Europe in US$ Million by Disorder: A Historic Review for the Period 2009-2017

TABLE 108: Rest of Europe Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 109: Rest of Europe Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 110: Antidepressants Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 111: Rest of Europe Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 112: Asia-Pacific Antidepressants Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 113: Antidepressants Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 114: Asia-Pacific Antidepressants Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 115: Antidepressants Market in Asia-Pacific by Disorder: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 116: Asia-Pacific Antidepressants Historic Market Scenario in US$ Million by Disorder: 2009-2017

TABLE 117: Asia-Pacific Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025

TABLE 118: Antidepressants Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 119: Asia-Pacific Antidepressants Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 120: Asia-Pacific Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 121: Antidepressants Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025

TABLE 122: Australian Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017

TABLE 123: Australian Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 124: Antidepressants Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 125: Australian Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 126: Australian Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

INDIA

TABLE 127: Indian Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025

TABLE 128: Indian Antidepressants Historic Market Review by Disorder in US$ Million: 2009-2017

TABLE 129: Antidepressants Market in India: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025

TABLE 130: Indian Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 131: Indian Antidepressants Historic Market Review by Product in US$ Million: 2009-2017

TABLE 132: Antidepressants Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

SOUTH KOREA

TABLE 133: Antidepressants Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025

TABLE 134: South Korean Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017

TABLE 135: Antidepressants Market Share Distribution in South Korea by Disorder: 2009 VS 2019 VS 2025

TABLE 136: Antidepressants Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 137: South Korean Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 138: Antidepressants Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 139: Rest of Asia-Pacific Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025

TABLE 140: Antidepressants Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017

TABLE 141: Rest of Asia-Pacific Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025

TABLE 142: Rest of Asia-Pacific Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 143: Antidepressants Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 144: Rest of Asia-Pacific Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 145: Latin American Antidepressants Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 146: Antidepressants Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 147: Latin American Antidepressants Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 148: Latin American Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025

TABLE 149: Antidepressants Historic Market Analysis in Latin America in US$ Million by Disorder: 2009-2017

TABLE 150: Latin American Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 151: Latin American Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 152: Antidepressants Historic Market Analysis in Latin America in US$ Million by Product: 2009-2017

TABLE 153: Latin American Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 154: Argentinean Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025

TABLE 155: Antidepressants Market in Argentina in US$ Million by Disorder: A Historic Review for the Period 2009-2017

TABLE 156: Argentinean Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 157: Argentinean Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 158: Antidepressants Market in Argentina in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 159: Argentinean Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

BRAZIL

TABLE 160: Antidepressants Market in Brazil by Disorder: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 161: Brazilian Antidepressants Historic Market Scenario in US$ Million by Disorder: 2009-2017

TABLE 162: Brazilian Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025

TABLE 163: Antidepressants Market in Brazil by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 164: Brazilian Antidepressants Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 165: Brazilian Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025

MEXICO

TABLE 166: Antidepressants Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025

TABLE 167: Mexican Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017

TABLE 168: Mexican Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 169: Antidepressants Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 170: Mexican Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 171: Mexican Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 172: Rest of Latin America Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025

TABLE 173: Antidepressants Market in Rest of Latin America by Disorder: A Historic Review in US$ Million for 2009-2017

TABLE 174: Rest of Latin America Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 175: Rest of Latin America Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 176: Antidepressants Market in Rest of Latin America by Product: A Historic Review in US$ Million for 2009-2017

TABLE 177: Rest of Latin America Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 178: The Middle East Antidepressants Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 179: Antidepressants Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 180: The Middle East Antidepressants Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 181: The Middle East Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025

TABLE 182: The Middle East Antidepressants Historic Market by Disorder in US$ Million: 2009-2017

TABLE 183: Antidepressants Market in the Middle East: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025

TABLE 184: The Middle East Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 185: The Middle East Antidepressants Historic Market by Product in US$ Million: 2009-2017

TABLE 186: Antidepressants Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

IRAN

TABLE 187: Iranian Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025

TABLE 188: Antidepressants Market in Iran: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017

TABLE 189: Iranian Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025

TABLE 190: Iranian Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 191: Antidepressants Market in Iran: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 192: Iranian Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025

ISRAEL

TABLE 193: Israeli Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025

TABLE 194: Antidepressants Market in Israel in US$ Million by Disorder: A Historic Review for the Period 2009-2017

TABLE 195: Israeli Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 196: Israeli Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 197: Antidepressants Market in Israel in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 198: Israeli Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 199: Saudi Arabian Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025

TABLE 200: Antidepressants Historic Market Analysis in Saudi Arabia in US$ Million by Disorder: 2009-2017

TABLE 201: Saudi Arabian Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 202: Saudi Arabian Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 203: Antidepressants Historic Market Analysis in Saudi Arabia in US$ Million by Product: 2009-2017

TABLE 204: Saudi Arabian Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 205: Antidepressants Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025

TABLE 206: United Arab Emirates Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017

TABLE 207: Antidepressants Market Share Distribution in United Arab Emirates by Disorder: 2009 VS 2019 VS 2025

TABLE 208: Antidepressants Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 209: United Arab Emirates Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 210: Antidepressants Market Share Distribution in United Arab Emirates by Product: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 211: Antidepressants Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025

TABLE 212: Rest of Middle East Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017

TABLE 213: Rest of Middle East Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 214: Antidepressants Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 215: Rest of Middle East Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 216: Rest of Middle East Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

AFRICA

TABLE 217: African Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025

TABLE 218: Antidepressants Market in Africa by Disorder: A Historic Review in US$ Million for 2009-2017

TABLE 219: African Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025

TABLE 220: African Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 221: Antidepressants Market in Africa by Product: A Historic Review in US$ Million for 2009-2017

TABLE 222: African Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

IV. COMPETITION

ALLERGAN PLC

ELI LILLY AND COMPANY

GLAXOSMITHKLINE PLC

H. LUNDBECK A/S

MERCK & CO., INC.

OTSUKA AMERICA PHARMACEUTICAL

PFIZER

TAKEDA PHARMACEUTICAL COMPANY LIMITED

TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • H. Lundbeck A/S
  • Merck & Co., Inc.
  • Otsuka America Pharmaceutical
  • Pfizer
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries
Note: Product cover images may vary from those shown
Adroll
adroll